10.1104/pp.103.035956 141 VadasseryJ.TripathiS.PrasadR.VarmaA.OelmllerR
Mice in particular (320) may be more sensitive to systemically administered FGF21 and FGF21 analogs than humans
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept
defined as unstable angina, myocardial infarction, or coronary artery procedures or surgeries) and composite cerebrovascular events (defined as the first occurrence of stroke, transient ischaemic attack, cerebral infarction, carotid intervention or surgery), and the secondary outcome was all-cause mortality
An oral methionine-loading test (100 mg/kg of body weight) is currently used to identify heterozygous patients who have normal fasting homocysteine levels